Meshima (Phellinus linteus).
Korean mushroom researched for womens cancers. Supplies beta-1,3/1,6-glucans from a hardwood bracket fungus. Those glucans are recognised by receptors on innate immune cells, which is the basis for using it for immune resilience.
Reviewed March 2026
- Category
- Mushroom
- Also filed under
- Immune modulationWomens healthCancer research
What Meshima (Phellinus linteus) is, and what it does.
- Does it work
- Good. Extensive Korean studies. Less Western awareness.
- How much to take
- Start with 500 to 1,000mg a day of a hot-water or dual extract. That band is where the beta-glucan fraction does its everyday work, and it suits continuous daily use.
- Time to feel it
- There is no same-day signal. Immune measures in the research move across weeks to months of daily use, so this is an ingredient you judge over a season.
- The first dose
- Day one passes quietly. The glucan reaches the colon intact, since human enzymes cannot break beta-1,3 links, and gut bacteria begin fermenting it there.
- With regular use
- Months of daily use is the tempo here. Immune measures in the research move over weeks to months, and the glucan also ferments in the colon into short-chain fatty acids.
- How well tolerated
- Well tolerated as a hot-water extract. Because it engages immune receptors, anyone on immune-modulating medication or under care for an immune condition should check with their doctor first.
- How it feels
- No day-to-day sensation. What people follow is how a winter goes and how quickly they bounce back, which is a pattern read over a season.
- The overlooked benefit
- That same indigestibility makes it a fermentable fibre on the way through, so a mushroom extract feeds the bacteria that produce short-chain fatty acids.
500 to 1,000mg a day is where Meshima (Phellinus linteus) works.
Source: Zhu et al., World J Gastroenterol, 2007; Song et al., FEMS Immunol Med Microbiol, 2003
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Meshima (Phellinus linteus) has emerging evidence. Based on 1+ studies.
- recognition by dectin-1 and complement receptor 3 on innate immune cellsIn vitro study
- immune cell signalling with Phellinus linteus polysaccharideAnimal study
- colonic fermentation of beta-1,3/1,6-glucan to short-chain fatty acidsIn vitro study
- antioxidant activity of the ethanol-soluble styrylpyrone fractionIn vitro study
Questions people ask about Meshima (Phellinus linteus).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Both are polypore fungi whose cell walls supply beta-1,3/1,6-glucans, the ligands innate immune cells recognise through dectin-1 and complement receptor 3. Blending two species widens the range of glucan branching and molecular weights presented at those receptors rather than relying on a single structure.
Meshima is used mainly for its polysaccharide fraction, while reishi contributes triterpenes alongside its own glucans, so the two cover different chemistry in one blend. This is standard mushroom-complex practice rather than a measured combination effect.
Maitake supplies a highly branched beta-glucan fraction that acts on the same innate recognition receptors as Phellinus polysaccharides. Formulators pair them to diversify glucan source material in a single serving.
Chaga and meshima are both Hymenochaetaceae polypores whose cell walls supply beta-1,3/1,6-glucans that engage dectin-1. Chaga adds a melanin-polyphenol fraction that meshima does not carry.
Lion's mane contributes hericenones and erinacines acting on nerve growth factor signalling, while meshima's contribution is its glucan and proteoglycan fraction. The two do not compete for the same target.
Cordyceps supplies cordycepin and adenosine analogues that act on cellular energy handling, a route separate from glucan receptor binding. Blends pair them so one formula carries both fractions.
Yeast beta-1,3/1,6-glucan binds the same dectin-1 and CR3 receptors that fungal glucans from meshima engage, but at a known and measurable purity. It is used to put a defined glucan amount behind a mushroom blend.
Astragalus polysaccharides and saponins act on innate immune signalling from a plant structure unlike fungal glucan. The two classes reach overlapping pathways from different molecular starting points.
Tremella's acidic glucuronoxylomannan holds water and behaves quite differently from a branched beta-glucan. Including both puts two polysaccharide chemistries in one formula.
Fungal ergosterol converts to vitamin D2 under UV light, so mushroom material can carry some D. Vitamin D receptor signalling also sits upstream of the innate pathways glucans engage.
Meshima's water-soluble fraction is largely beta-1,3/1,6-glucan, the same structural class recognised by dectin-1 and complement receptor 3 on innate immune cells. A purified beta-glucan and a mushroom extract therefore present overlapping ligands rather than complementary ones. Stacking them raises total glucan load without adding a second mechanism.
Shiitake contributes lentinan-type beta-glucan from a different species, so blends carry a broader range of glucan branching and molecular weights. Receptor recognition depends on that structure, not on the species name. Blend effects belong to the blend and not to any single mushroom in it.
Human enzymes cannot hydrolyse fungal beta-glucan or inulin, so both arrive in the colon for microbial fermentation to short-chain fatty acids. Pairing them widens the substrate range available to the resident community. Which organisms use which substrate varies between people.
Undigested mushroom polysaccharide reaches the colon where added organisms are working, which is the standard rationale for putting a fungal extract next to a culture. The extract supplies fermentable material, the culture supplies fermentation capacity. The pairing is mechanistic rather than the subject of a shared trial.
Zinc is required by hundreds of enzymes and transcription factors involved in normal immune cell development and function. A beta-glucan that engages innate receptors and a mineral that the responding cells depend on act at different points of the same system. Cofactor sufficiency is a precondition, not an added effect.
Ascorbate participates in the redox recycling network that regenerates oxidised phenolic antioxidants, including the styrylpyrone-type phenolics found in Phellinus species. The interaction is chemistry that has been characterised in solution. Antioxidant capacity in a test tube is a marker and not a clinical outcome.
Selenium is the catalytic centre of glutathione peroxidases and thioredoxin reductases, the enzymes that handle peroxides inside immune cells. Mushroom phenolics act on the chemical side of redox handling and selenoenzymes act on the enzymatic side. The two are complementary parts of one system.
Mushrooms carry ergosterol, which ultraviolet exposure converts to vitamin D2, a different molecule from the D3 in supplements. Vitamin D receptor signalling in innate immune cells sits downstream of the receptors beta-glucan engages. The species of vitamin D matters and should be stated rather than blurred.
Quercetin and the mushroom's phenolic fraction share phase II conjugation routes and both act as hydrogen donors in redox chemistry. Formulas combine them for phenolic breadth. Shared conjugation also means shared capacity, so more is not simply additive.
Both are plant and fungal stilbene-family or styrylpyrone-family phenolics handled by sulphation and glucuronidation after absorption. Pairing broadens the phenolic profile of a formula. Bioavailability for both is limited and highly variable between people.
Rhodiola sits in the adaptogen category alongside medicinal mushrooms in traditional and modern blends, and the two act through unrelated chemistry. The pairing is a formulation convention with a long history of use. History of use is not the same as measured combination evidence.
Schisandra lignans and Phellinus polysaccharides are combined in traditional East Asian formulas rather than on a shared mechanism. The lignans are lipophilic and the polysaccharides water-soluble, so they extract into different solvent fractions. A dual extraction is what puts both into one product.
Silymarin flavonolignans and mushroom polysaccharides appear together in formulas aimed at normal liver function, working through unrelated chemistry. Neither depends on the other. The pairing is formulation practice and should not be read as a measured combined effect.
Propolis contributes caffeic acid esters and flavonoids to a formula whose mushroom component contributes polysaccharide and styrylpyrones. The chemistry is distinct and the intended use overlaps. Both are highly variable in composition by source, so specifications matter more than names.
Elderberry anthocyanins and mushroom beta-glucans are combined in seasonal support formulas through separate chemistry. Neither modifies the other's absorption in any characterised way. The pairing is convention, not a tested combination.
Charcoal adsorbs polyphenols and other co-ingested organic molecules without selectivity. Taken in the same window it reduces what is available from a phenolic-containing extract. Space the two by several hours.
Phenolic compounds bind non-heme iron in the gut lumen and reduce the fraction available for absorption. A phenolic-rich mushroom extract taken with an iron dose is subject to the same chemistry as tea or coffee. Separating the doses is the practical response.
Nothing specific on file for Meshima (Phellinus linteus). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Meshima (Phellinus linteus) actually does.
The part that dissolves in hot water is mostly a long branched sugar chain, sometimes attached to protein.
Immune cells have receptors that latch onto this type of sugar chain, and its exact shape matters more than which mushroom it came from.
We cannot digest these sugar chains ourselves, so gut bacteria ferment them further down.
Hot water pulls out the sugar chains and alcohol pulls out different, oilier compounds, so the solvent decides what is in the bottle.
Getting Meshima (Phellinus linteus) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In 98 adults taking 1,000 mg of Phellinus linteus extract daily for 8 weeks, natural killer cell activity rose significantly compared with placebo, while the cytokine and immunoglobulin measures showed no significant change.Randomised trial. Ku et al., 2022 (Medicine). PMID 36042633 ↗
- In a 30-person pilot at 1,000 mg or 2,000 mg daily for 8 weeks, natural killer cell activity and interleukin-6 trended upward against placebo, but the differences did not reach statistical significance.Randomised trial. Ku and Kang, 2022 (Medicine). PMID 36221338 ↗
These are the studies our verdict leans on, chosen from the 309 we read for Meshima (Phellinus linteus). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.